GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » PS Ratio

Dr Reddy's Laboratories (Dr Reddy's Laboratories) PS Ratio

: 3.61 (As of Today)
View and export this data going back to 2001. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Dr Reddy's Laboratories's share price is $71.07. Dr Reddy's Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $19.68. Hence, Dr Reddy's Laboratories's PS Ratio for today is 3.61.

Warning Sign:

Dr Reddy's Laboratories Ltd stock PS Ratio (=3.72) is close to 2-year high of 3.96

The historical rank and industry rank for Dr Reddy's Laboratories's PS Ratio or its related term are showing as below:

RDY' s PS Ratio Range Over the Past 10 Years
Min: 2.27   Med: 3.37   Max: 4.9
Current: 3.7

During the past 13 years, Dr Reddy's Laboratories's highest PS Ratio was 4.90. The lowest was 2.27. And the median was 3.37.

RDY's PS Ratio is ranked worse than
71.37% of 1006 companies
in the Drug Manufacturers industry
Industry Median: 2.15 vs RDY: 3.70

Dr Reddy's Laboratories's Revenue per Sharefor the three months ended in Dec. 2023 was $5.20. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $19.68.

During the past 12 months, the average Revenue per Share Growth Rate of Dr Reddy's Laboratories was 14.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.70% per year.

During the past 13 years, Dr Reddy's Laboratories's highest 3-Year average Revenue per Share Growth Rate was 46.10% per year. The lowest was -0.50% per year. And the median was 11.50% per year.

Back to Basics: PS Ratio


Dr Reddy's Laboratories PS Ratio Historical Data

The historical data trend for Dr Reddy's Laboratories's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PS Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.97 3.96 3.34 3.13

Dr Reddy's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.97 3.13 3.29 3.49 3.56

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories PS Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's PS Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's PS Ratio falls into.



Dr Reddy's Laboratories PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Dr Reddy's Laboratories's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=71.07/19.683
=3.61

Dr Reddy's Laboratories's Share Price of today is $71.07.
Dr Reddy's Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $19.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Dr Reddy's Laboratories  (NYSE:RDY) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Dr Reddy's Laboratories PS Ratio Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Headlines

From GuruFocus

Dr. Reddy's Q1 FY24 Financial Results

By Business Wire 07-26-2023